Breakthroughs come from unexpected places.
At Alector, we know that discoveries can only come from boundless curiosity. We are driven to tap into that spirit of inquisitiveness and imagination as we seek to improve the lives of people living with devastating neurodegenerative diseases.
The resolve to confront the unmet needs in neurodegenerative disease treatment.
We imagine a different world. One where lives are not hopelessly upended by neurodegeneration. To transform this vision into reality, we are combining advanced science and technology with deep expertise to develop therapies that address critical challenges in neurodegenerative diseases and improve brain health.
A pipeline of potential first and best-in-class medicines.
We’re advancing a pipeline of potential first- and best-in-class medicines based on our insights into human genetics, neuroscience, and immunology. Our therapeutic candidates are designed to remove toxic proteins, replace deficient proteins, and restore immune and nerve cell function. Our development strategy seeks to gather disease- and drug-specific insights sooner, apply lessons quickly, and increase our probability of success.
Helping patients is our purpose.
What if diseases of aging weren’t an inevitability? What if we could slow or even halt the seemingly inescapable path toward decline associated with certain conditions? We exist to ask these bold questions, and we seek answers by advancing an understanding of diseases as we discover and develop innovative therapeutic candidates that we hope may someday make a profound impact on people’s lives.
We live a culture of courage.
We relish a challenge and bring a spirit of curiosity, empathy, and collaboration to our daily work. This mindset motivates and guides us as we forge new paths to deliver urgently needed, potentially transformative therapeutics.
